Time to pull the plug on auto-renewed third party electric contracts!
AARP Connecticut has worked for over a 17 years to address and rectify the fraud, misleading advertising and unscrupulous practices that have plagued and undermined Connecticut’s deregulated third-party electric market place. This has frequently resembled a game of whack-a-mole with a new scheme or trick popping up every time AARP and other consumer advocates knock down a deceptive supplier tactic through legislation or a Public Utilities Regulatory Authority ruling.
John Erlingheuser
Ratepayers in Connecticut pay the highest rates in the continental United States. Those entering third party electric supplier contracts to save money frequently find that what seems like a good deal initially turns into a costly mistake in the end. This is due to an anti-consumer provision of these supplier contracts that allows them to be auto-renewed at their conclusion.
Improving Diversity In Clinical Trials
Source: Life Science Leader
The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID pandemic. In fact, a key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this ebook come from varying backgrounds, and as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups
FDA warns pulse oximeters less accurate for people with darker skin mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Turning Point In U.S. History: Our Chance To Do Better With Clinical Trials
By Charlotte Jones-Burton, MD, VP of Clinical Development-Nephrology, Otsuka
Over a decade ago, I made the decision to transition from being a full-time physician to designing and executing clinical trials to help develop the innovative therapies that will transform and shape the future of medicine. As I transitioned to this new role, I could not help but notice there were not many people who looked like me a black woman. The more I became acclimated within the industry, the more heightened my awareness of the fractured healthcare system became.